Breast-specific gamma imaging developer Dilon Diagnostics has become the exclusive distributor of SurgicEye's intraoperative soft-tissue imaging and navigation products in the U.S.
SurgicEye's declipseSPECT/CSS300 gamma probe is designed for intraoperative 3D image visualization and navigation during radio-guided surgery.
The technology, which has received clearance by the U.S. Food and Drug Administration (FDA), combines imaging and image viewing as a tool to resect radioactively labeled structures, such as primary breast tumors, metastases, and sentinel lymph nodes, using a minimally invasive approach.
